This medication is used to treat certain bowel disorders (ulcerative colitis, Crohn’s disease). In these conditions, the body’s defense system (immune system) attacks healthy tissues in the gut, causing symptoms such as abdominal pain, blood in the stool, and diarrhea. Vedolizumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking the actions of a certain natural substance (integrin) in the body. This helps to decrease swelling (inflammation) in the gut, which lessens symptoms and may slow or stop damage from these bowel disorders. Vedolizumab Solution, Reconstituted (Recon Soln) –
GENERIC NAME: VEDOLIZUMAB
Are you looking for or in search of FDA approved “vedolizumab for injection in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for crohns disease, ulcerative colitis. Need Access of vedolizumab for injection, get in touch with our healthcare professional.
Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Millennium Pharmaceuticals, Inc. for the treatment of ulcerative colitis and Crohn’s disease. It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer’s patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7). Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity.
lcerative colitis and Crohn’s disease
Vedolizumab has been approved for use in adults with moderate to severe ulcerative colitis or Crohn’s disease having a poor response to tumor necrosis factor (TNF) blockers or corticosteroids, or for those who are steroid-dependent.
Checkpoint inhibitor colitis
Vedolizumab may be used to treat steroid refractory checkpoint inhibitor induced colitis, if infliximab is ineffective or contraindicated.